Bevacizumab inhibits proliferation of choroidal endothelial cells by regulation of the cell cycle
Raluca Rusovici, Chirag J Patel, Kakarla V ChalamUniversity of Florida, Department of Ophthalmology, Jacksonville, FL, USABackground: The purpose of this study was to evaluate cell cycle changes in choroidal endothelial cells treated with varying doses of bevacizumab in the presence of a range of co...
Saved in:
Main Authors: | Rusovici R, Patel CJ, Chalam KV |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/fe25b94aa8bb4a6685f11c565a4a97ed |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Choroidal osteoma with choroidal neovascular membrane: Successful treatment with intravitreal bevacizumab
by: Neeraj Pandey, et al.
Published: (2010) -
Long-term success of intravitreal bevacizumab for choroidal neovascularization associated with choroidal osteoma
by: Kubota-Taniai M, et al.
Published: (2011) -
Spectral domain optical coherence tomography documented rapid resolution of pseudophakic cystoid macular edema with topical difluprednate
by: Chalam KV, et al.
Published: (2012) -
Choroideremia associated with choroidal neovascularization treated with intravitreal bevacizumab
by: Palejwala NV, et al.
Published: (2014) -
Long-term outcomes of intravitreal injection of bevacizumab for choroidal neovascularization associated with choroidal osteoma
by: Yoshikawa T, et al.
Published: (2015)